Yuki Gosei Kogyo Posts Higher Sales but Sharp Profit Decline and Cuts Full-Year Outlook

An update from Yuki Gosei Kogyo Co., Ltd. ( (JP:4531) ) is now available.

Yuki Gosei Kogyo reported non-consolidated net sales of ¥11,017 million for the nine months ended December 31, 2025, a modest 1.6% increase year on year, but saw profitability weaken sharply, with operating income down 41.5% to ¥364 million and net income falling 49.4% to ¥238 million, pushing net income per share down to ¥11.06. Despite a slight increase in total assets and net assets and an equity ratio holding around 49%, the company cut its full-year profit outlook even as it projects small growth in sales, now forecasting net sales of ¥15.3–15.5 billion but a steep decline in full-year operating and ordinary income versus the previous year, underscoring pressure on margins. Dividend policy remains shareholder-friendly but conservative, with no interim dividend and a planned year-end dividend of ¥10 per share for the fiscal year ending March 31, 2026, signaling an intention to maintain returns to investors while navigating a period of earnings compression.

The most recent analyst rating on (JP:4531) stock is a Hold with a Yen499.00 price target. To see the full list of analyst forecasts on Yuki Gosei Kogyo Co., Ltd. stock, see the JP:4531 Stock Forecast page.

More about Yuki Gosei Kogyo Co., Ltd.

Yuki Gosei Kogyo Co., Ltd., listed on the Tokyo Stock Exchange, operates in the chemical and related materials sector, supplying specialized products that support industrial and pharmaceutical value chains in Japan and abroad. The company’s earnings are closely tied to trends in demand for fine and specialty chemicals, where stable sales volumes can contrast with volatile profitability depending on input costs, product mix, and pricing power.

Average Trading Volume: 289,957

Technical Sentiment Signal: Buy

Current Market Cap: Yen10.69B

For a thorough assessment of 4531 stock, go to TipRanks’ Stock Analysis page.